Hong, NH. et al. Advances in the Development of a Targeted N-Terminal Domain Androgen Receptor Degrader (ANITAC) for the Treatment of Prostate Cancer. 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics.

Read More > EORTC-NCI-AACR 2022 Poster Presentation